홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Cyclopentylacetyl chloride → 2-Cyclopentyl-1-[4-(3-pyridin-4-yl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]ethanone

HRID 221360
인쇄

반응식

HRID 221360 반응식
N1CCC(O[CH2:8][C:9]2[O:13][N:12]=[C:11]([C:14]3[CH:19]=[CH:18][N:17]=[CH:16][CH:15]=3)[N:10]=2)CC1.[CH:20]1([CH2:25][C:26](Cl)=[O:27])[CH2:24][CH2:23][CH2:22][CH2:21]1>>[CH:20]1([CH2:25][C:26]([N:10]2[CH2:11][CH2:14][CH:8]([C:9]3[O:13][N:12]=[C:11]([C:14]4[CH:15]=[CH:16][N:17]=[CH:18][CH:19]=4)[N:10]=3)[CH2:8][CH2:9]2)=[O:27])[CH2:24][CH2:23][CH2:22][CH2:21]1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 3485182Cyclopentylacetyl chlorideHCID 579543974-[5-(Piperidin-4-yloxymethyl)-[1,2,4]oxadiazol-3-yl]-pyridine

생성물 1

HCID 579544052-Cyclopentyl-1-[4-(3-pyridin-4-yl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]ethanone

실험 절차

4-[5-(Piperidin-4-yloxymethyl)-[1,2,4]oxadiazol-3-yl]pyridine (Example 51) was reacted with cyclopentylacetyl chloride, in a similar manner to that described in Example 55, to afford the title compound: RT=3.44 min, m/z (ES+)=341.3 [M+H]+.

출처 및 근거

ORD 기록
ord-a616ccc788074adca47bb0f078ad85bb
출처 데이터셋
uspto-grants-2012_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08207147B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트